Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK… Grant US-11786529-B2 United States of America 17 Oct 2023
Treatment of B cell cancers using a combination comprising Btk inhibitors Grant US-11701357-B2 United States of America 18 Jul 2023
Anti-PD1 antibodies and their use as therapeutics and diagnostics Grant US-11673951-B2 United States of America 13 Jun 2023